Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

927
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
927
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

812
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
812
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracing illicit and prescription drug use in a Spanish prison by combining wastewater analysis and pharmaceutical dispensing data.

Environmental toxicology and pharmacology·2026
Same author

Recent advances in the use of gelatin as a biomaterial for tissue engineering.

International journal of pharmaceutics·2026
Same author

Oral health in people with schizophrenia: associations with behavioural and pharmacological factors.

Epidemiology and psychiatric sciences·2026
Same author

2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension League.

Journal of hypertension·2026
Same author

Designing at-source and end-of-pipe biotechnologies to tackle pharmaceutical pollution.

Trends in biotechnology·2025
Same author

Promoting sustainable pharmacy for tackling environmental pharmaceutical pollution.

Drug discovery today·2025

Related Experiment Video

Updated: Apr 29, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K

Possible interaction between letrozole and long-acting injectable zuclopenthixol.

Unax Lertxundi1, Rafael Hernandez, Juan Medrano Albeniz

  • 1Unax Lertxundi, Pharm.D., Pharmacy Service, Red de Salud Mental de Araba , C/Alava 43, 01006 Vitoria-Gasteiz, Alava , Spain .

Nordic Journal of Psychiatry
|May 17, 2014
PubMed
Summary

A potential drug interaction between letrozole and zuclopenthixol may cause severe extrapyramidal symptoms in patients. Physicians should monitor for this interaction, especially in patients with schizophrenia undergoing cancer treatment.

Keywords:
Drug interactionsletrozolezuclopenthixol

More Related Videos

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K
Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
12:02

Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds

Published on: August 8, 2020

6.0K

Related Experiment Videos

Last Updated: Apr 29, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K
Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
12:02

Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds

Published on: August 8, 2020

6.0K

Area of Science:

  • Pharmacology
  • Oncology
  • Neurology

Background:

  • This case report details a patient with paranoid schizophrenia on long-term antipsychotic treatment.
  • The patient was diagnosed with breast cancer and initiated on letrozole therapy.

Observation:

  • Progressive development of severe extrapyramidal symptoms, including sedation, dystonia, and dysphagia, occurred after initiating letrozole.
  • These symptoms were exacerbated by zuclopenthixol administration and improved significantly after biperiden treatment.

Findings:

  • A potential drug-drug interaction between letrozole and zuclopenthixol is suspected, leading to zuclopenthixol accumulation.
  • This interaction is characterized by a slow onset and progressive worsening of neurological symptoms.

Implications:

  • This is the first reported case suggesting an interaction between letrozole and zuclopenthixol.
  • Healthcare providers should be vigilant for this potentially serious interaction and consider monitoring patients closely.